A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT05856448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subjects With Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).
Study identification
- NCT ID
- NCT05856448
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 186 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2023 (Actual)
- Primary completion
- Oct 8, 2025 (Actual)
- Completion
- Feb 27, 2026 (Actual)
- Last update posted
- May 14, 2026
2023 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 8
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona College of Medicine - Tucson | Tucson | Arizona | 85724 | — |
| University of California San Diego | La Jolla | California | 92037 | — |
| Desert Medical Advances | Rancho Mirage | California | 92270 | — |
| Millennium Clinical Trials | Simi Valley | California | 93064 | — |
| Inland Rheumatology Clinical Trials | Upland | California | 91786 | — |
| Upland Rheumatology Center | Upland | California | 91786 | — |
| Arthritis & Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| Omega Research DeBary | DeBary | Florida | 32713 | — |
| Alloy Clinical Research, LLC | Kissimmee | Florida | 34741 | — |
| San Marcus Research Clinic | Miami | Florida | 33014 | — |
| Advanced Pharma - Miami | Miami | Florida | 33147 | — |
| Professional Research Center | Miami | Florida | 33172 | — |
| Integral Rheumatology & Immunology Specialists | Plantation | Florida | 33324 | — |
| Alliance Clinical Research of Tampa | Tampa | Florida | 33615 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28211 | — |
| Lynn Institute of Tulsa | Tulsa | Oklahoma | 74135 | — |
| New Phase Research & Development | Knoxville | Tennessee | 37909 | — |
| Office of Ramesh C. Gupta MD / Shelby Research LLC - Tennessee | Memphis | Tennessee | 38119 | — |
| Care and Cure Clinic | Houston | Texas | 77090 | — |
| Southwest Arthritis | Mesquite | Texas | 75150 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05856448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05856448 live on ClinicalTrials.gov.